A new prognostic strategy for gastric carcinoma: albumin level and metastatic lymph node ratio.
Minerva Chir
; 69(3): 147-53, 2014 Jun.
Article
en En
| MEDLINE
| ID: mdl-24970303
ABSTRACT
AIM:
We evaluated the prognostic significance of preoperative serum albumin value and metastatic lymph node ratio for gastric cancer patients.METHODS:
We studied patients diagnosed with gastric carcinoma in the first Department of Surgery, Bezmialem Vakif Gureba Training and Research Hospital between January 2004 and December 2010; the patients were studied retrospectively.RESULTS:
A total of 67 patients with a mean age of 58.7 ± 11.4 years were included in the study. The majority of patients were male (N.=53 male; N.=14 female). Most patients were in an advanced stage of the disease (stage III-IV) on admission (67.2%). We classified patients according to albumin value as "normal" Group 1 (83%) and "hypoalbuminemic" Group 2 (17%). With albumin, age, resection type, perineural invasion, and ratio of metastatic lymph nodes, T and TNM stages were significant predictors of cancer-specific survival.CONCLUSION:
As a result, irrespective of mechanism, pre-operative evaluations of albumin and metastatic lymph node ratio should be performed to stratify the patients for risk analysis and prognosis. A level less than 3.5 g/dL is a negative prognostic factor for resectable gastric cancers.
Buscar en Google
Banco de datos:
MEDLINE
Asunto principal:
Neoplasias Gástricas
/
Carcinoma
/
Biomarcadores de Tumor
/
Albúminas
/
Ganglios Linfáticos
Tipo de estudio:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Minerva Chir
Año:
2014
Tipo del documento:
Article